Information on the MBS items for medication management reviews:
- Domiciliary Medication Management Review (DMMR), a collaborative medication review for people in the community (item number 900); and
- Residential Medication Review (RMMR) for residents of aged care facilities (item number 903).
Domiciliary Medication Management Review (DMMR)
The Domiciliary Medication Management Review (DMMR), also known as a Home Medicines Review (HMR), is an MBS item for patients living in the community setting. This may only be initiated by a patient’s GP after assessing the patient’s need for the service.
The goal of a DMMR is to maximise an individual patient’s benefit from their medication regimen, and prevent medication-related problems through a team approach, involving the patient’s GP and preferred community pharmacy. It may also involve other relevant members of the health care team, such as nurses in community practice or carers.
The DMMR process utilises the specific knowledge and expertise of each of the health care professionals involved. In collaboration with the GP, a pharmacist comprehensively reviews the patient’s medication regimen in a home visit. After discussion of the pharmacist’s report and findings, the GP and patient agree on a medication management plan. The patient is central to the development and implementation of this plan with their GP. Payment for the review under the MBS will not occur until after the second patient consultation.
A copy of the DMMR Plan and the DMMR Referral Form does not need to be sent to the Australian Government Department of Health and Ageing.
Residential Medication Management Review (RMMR)
The Residential Medication Management Review (RMMR) is an MBS item for permanent residents of a residential aged care facility (RACF). It involves collaboration between a GP and a pharmacist to review the medication management needs of a resident.
A RMMR is for residents who are likely to benefit from such a service. In particular, it is for residents for whom quality use of medicines may be an issue, or who are at risk of medication misadventure because of a significant change in their condition or medication regimen.
The need for an RMMR can be identified by the resident, the resident’s carer or a member of the resident’s health care team.
The team could include staff of the aged care home, the resident’s doctor, the pharmacist providing medication management review services in an aged care home, or a pharmacist supplying medication to the resident. However, the resident’s doctor must assess the resident and decide whether an RMMR is clinically necessary. As with DMMRs, payment for the review under the MBS will not occur until after the second patient consultation.